secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001411690-25-000092
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Q3 revenue $7.4M (+21% YoY); raises FY 2025 OGM install guidance
------------------------------------------------------------------------

- Total revenue $7.4M, up 21% from $6.1M in Q3 2024; consumables/software revenue +15%.
- GAAP gross margin 46% vs (139)% a year ago; non-GAAP gross margin 46% vs 26%.
- Operating expenses cut 66% to $11.9M; cash and investments $31.8M at quarter-end.
- Raised FY 2025 OGM system install guidance to >25 units (prior 20-25).
- Reiterated FY 2025 revenue guidance $26-30M; Q4 2025 revenue guided $7.5-7.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169025000092/0001411690-25-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169025000092/bngo-20251113.htm
  HTML page:      https://secwatch.observer/filing/0001411690-25-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer